Cellular and Molecular Biology
by CMB Association
Quick jump to page content
Main Navigation
Main Content
Sidebar
Home
About
About the Journal
Aims and Scope
Editorial Policies
Editorial Board
Peer review policy
Publication Ethics
Guiding Principles for Research Involving Animals and Human Beings
Corrections Retractions and Matters Arising
Consent Policy
Privacy Statement
Advertising policy
Special Issue Proposal
Contact
Articles online first
Current
Archives
Call For Papers
Search
Home
Archives
Vol. 55 No. 1: Porphyrias and associated pathologies. Biochemistry and molecular biology Part 1
Published:
February 16, 2009
Original Research Articles
Peroxidase activity of cytochrome c facilitates the protoporphyrinogen oxidase reaction
February 16, 2015
6-14
M Shepherd, H A Dailey
PDF
Four novel mutations of the coproporphyrinogen III oxidase gene
February 16, 2015
15-18
C Aurizi, G Lupia Palmieri, L Barbieri, A Macrí¬, F Sorge, G Usai, G Biolcati
PDF
Awareness is the name of the game: Clinical and biochemical evaluation of a case of a girl diagnosed with acute intermittent porphyria associated with autism
February 16, 2015
19-22
A S Luder, R Mamet, I Farbstein, N Schoenfeld
PDF
Glutamatergic system: Another target for the action of porphyrinogenic agents
February 16, 2015
23-28
J V Lavandera, M Fossati, J Azcurra, A Batlle, A M Buzaleh
PDF
Epidermal growth factor receptor ligands in murine models for erythropoietic protoporphyria: Potential novel players in the progression of liver injury
February 16, 2015
29-37
C Berasain, A Sampedro, I Mauleon, S Goñi, M U Latasa, N Matscheko, M Garcia-Bravo, C Unzu, F J Corrales, R. Enriquez De Salamanca, J Prieto, M A ívila, A Fontanellas
PDF
Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria
February 16, 2015
38-44
A M Buzaleh, M J Morán-Jiménez, M Garcia-Bravo, A Sampedro, A M Del C Batlle, R Enriquez De Salamanca, A Fontanellas
PDF
Excessive erythrocyte ppix influences the hematologic status and iron metabolism in patients with dominant erythropoietic protoporphyria
February 16, 2015
45-52
C Delaby, S Lyoumi, S Ducamp, C Martin-Schmitt, L Gouya, J C Deybach, C Beaumont, H Puy
PDF
Congenital erythropoietic porphyria: Mutation update and correlations between genotype and phenotype
February 16, 2015
53-60
C GED, F Moreau-Gaudry, E Richard, E Robert-Richard, H De Verneuil
PDF
The very first description of a patient with hepatoerythropoietic porphyria in Argentina. Biochemical and molecular studies
February 16, 2015
61-65
B X Granata, V E Parera, V A Melito, M J Teijo, A M Del C Batlle, M V ROSSETTI
PDF
Porphyrin precursors and porphyrins in three patients with acute intermittent porphyria and end-stage renal disease under different therapyREGIMES
February 16, 2015
66-71
E Sardh, D E H Andersson, A Henrichson, P Harper
PDF
Neurological manifestations of acute intermittent porphyria
February 16, 2015
72-83
E Pischik, R Kauppinen
PDF
A systematic review of treatment options for dermal photosensitivity in erythropoietic protoporphyria
February 16, 2015
84-97
E I Minder, X SchneideR-Yin, J Steurer, L M Bachmann
PDF
Does bilirubin level correspond to interaction of c.-3279T>G and A(TA)7TAA variants in UGT1A1 gene?
February 16, 2015
98-101
L Slachtova, D Kemlink, P Martasek, P Kabicek
PDF
5-Aminolevulinate synthase: Catalysis of the first step of heme biosynthesis
February 16, 2015
102-110
G A Hunter, G C Ferreira
PDF
Editorial
Foreword
February 16, 2009
1-5
A Batlle, M V Rossetti
PDF
Editorial Pick
Indexed in
https://www.cellmolbiol.org/index.php/CMB
Themes by Openjournaltheme.com
Themes by Openjournaltheme.com